Intellia Therapeutics, Inc. SEC filings NTLA

Intellia Therapeutics, Inc. has 721 filings in SEC EDGAR's recent list, going back to Sep 3, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Intellia Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 8, 2026
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Sep 4, 2026 Sep 4, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 15, 2026 Jun 13, 2026
8-K Current report
Shareholder vote results
Jun 10, 2026 Jun 9, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 11, 2026 May 11, 2026
8-K Current report
Material agreement, Results of operations
Apr 30, 2026 Apr 27, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 9, 2026
424B5 Prospectus supplement Apr 29, 2026 —
424B5 Prospectus supplement Apr 27, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Apr 27, 2026 Apr 27, 2026
8-K Current report
Bylaw or fiscal year change
Apr 10, 2026 Apr 7, 2026
424B5 Prospectus supplement Mar 2, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Mar 2, 2026 Mar 2, 2026
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 27, 2026 Jan 27, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 9, 2026 Jan 9, 2026
8-K Current report
Regulation FD disclosure, Other events
Nov 10, 2025 Nov 8, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 27, 2025 Oct 27, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 25, 2025 Sep 25, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change
Aug 7, 2025 Aug 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2025 Jun 15, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2025 Jun 11, 2025
S-8 Employee stock plan registration Jun 11, 2025 —
8-K Current report
Regulation FD disclosure, Other events
May 28, 2025 May 28, 2025
8-K Current report
Regulation FD disclosure, Other events
May 19, 2025 May 18, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 11, 2025
8-K Current report
Bylaw or fiscal year change
Apr 7, 2025 Apr 3, 2025
S-8 Employee stock plan registration Feb 28, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Material agreement, New debt
Feb 21, 2025 Feb 18, 2025
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
Jan 10, 2025 Jan 9, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 18, 2024 Nov 16, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 25, 2024 Oct 24, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
S-8 Employee stock plan registration Jul 18, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 26, 2024 Jun 21, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 14, 2024 Jun 12, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 13, 2024 Jun 12, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 12, 2024
PRE 14A Preliminary proxy statement Apr 16, 2024 Jun 12, 2024
8-K Current report
Officer or director change
Apr 15, 2024 Apr 10, 2024
8-K Current report
Agreement ended
Mar 22, 2024 Mar 19, 2024
424B5 Prospectus supplement Feb 26, 2024 —
424B5 Prospectus supplement Feb 23, 2024 —
8-K Current report
Material agreement
Feb 23, 2024 Feb 23, 2024
S-8 Employee stock plan registration Feb 22, 2024 —
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 22, 2024 Feb 22, 2024
8-K Current report
Regulation FD disclosure
Feb 1, 2024 Jan 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 4, 2024 Jan 4, 2024
8-K Current report
Officer or director change
Dec 6, 2023 Dec 5, 2023
S-3ASR Automatic shelf registration Nov 24, 2023 —
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 2, 2023 Nov 2, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 18, 2023 Oct 18, 2023
8-K Current report
Regulation FD disclosure, Other events
Oct 3, 2023 Oct 3, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 16, 2023 Jun 14, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 12, 2023 Jun 11, 2023
DEFA14A Additional proxy material Jun 5, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 5, 2023 Jun 5, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
PRE 14A Preliminary proxy statement Apr 18, 2023 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 17, 2023 Apr 14, 2023
8-K Current report
Officer or director change
Mar 24, 2023 Mar 23, 2023
8-K Current report
Other events
Mar 2, 2023 Mar 2, 2023
S-8 Employee stock plan registration Feb 23, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 5, 2023 Jan 5, 2023
8-K Current report
Material agreement
Dec 1, 2022 Nov 30, 2022
424B5 Prospectus supplement Dec 1, 2022 —
8-K Current report
Regulation FD disclosure, Other events
Nov 14, 2022 Nov 12, 2022
8-K Current report
Regulation FD disclosure, Other events
Nov 7, 2022 Nov 5, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 16, 2022 Sep 16, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Other events
Jun 24, 2022 Jun 24, 2022
8-K Current report
Shareholder vote results
Jun 15, 2022 Jun 14, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Officer or director change
May 3, 2022 Apr 28, 2022
DEFA14A Additional proxy material May 2, 2022 —
DEF 14A Proxy statement May 2, 2022 Jun 14, 2022
8-K Current report
Material agreement
Mar 4, 2022 Mar 4, 2022
424B5 Prospectus supplement Mar 4, 2022 —
8-K Current report
Other events
Mar 4, 2022 Feb 28, 2022
8-K Current report
Regulation FD disclosure, Other events
Feb 28, 2022 Feb 28, 2022
S-8 Employee stock plan registration Feb 24, 2022 —
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 3, 2022 Feb 2, 2022
8-K Current report
Results of operations
Jan 6, 2022 Jan 6, 2022
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Material agreement
Jul 2, 2021 Jun 29, 2021
424B5 Prospectus supplement Jul 1, 2021 —
424B5 Prospectus supplement Jun 28, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Jun 28, 2021 Jun 26, 2021
8-K Current report
Shareholder vote results
Jun 24, 2021 Jun 23, 2021
8-K Current report
Officer or director change, Other events
Jun 22, 2021 Jun 21, 2021
8-K Current report
Material agreement, Other events
Jun 17, 2021 Jun 14, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 28, 2021 —
DEF 14A Proxy statement Apr 28, 2021 Jun 23, 2021
8-K Current report
Officer or director change
Apr 12, 2021 Apr 9, 2021
S-8 Employee stock plan registration Feb 26, 2021 —
10-K Annual report Feb 26, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Results of operations, Other events
Jan 7, 2021 Jan 7, 2021
8-K Current report
Material agreement, Other events
Dec 2, 2020 Dec 1, 2020
424B5 Prospectus supplement Dec 2, 2020 —
424B5 Prospectus supplement Nov 30, 2020 —
S-3ASR Automatic shelf registration Nov 30, 2020 —
8-K Current report
Other events
Nov 9, 2020 Nov 9, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Other events
Oct 19, 2020 Oct 19, 2020
8-K Current report
Officer or director change
Oct 5, 2020 Oct 2, 2020
CT ORDER Filing Sep 1, 2020 —
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Shareholder vote results
Jun 19, 2020 Jun 18, 2020
8-K Current report
Material agreement, Other events
Jun 3, 2020 Jun 1, 2020
424B5 Prospectus supplement Jun 3, 2020 —
424B5 Prospectus supplement Jun 1, 2020 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 1, 2020 May 30, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Jun 18, 2020
8-K Current report
Bylaw or fiscal year change
Apr 9, 2020 Apr 3, 2020
8-K Current report
Other events
Mar 26, 2020 Mar 26, 2020
8-K Current report
Material agreement, New debt
Mar 13, 2020 Mar 12, 2020
S-8 Employee stock plan registration Feb 27, 2020 —
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
8-K Current report
Results of operations, Other events
Jan 9, 2020 Jan 9, 2020
8-K Current report
Other events
Dec 16, 2019 Dec 13, 2019
10-Q Quarterly report Oct 31, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 31, 2019 Oct 31, 2019
8-K Current report
Other events
Sep 26, 2019 Sep 26, 2019
EFFECT Filing Sep 12, 2019 —
CORRESP Letter to the SEC Sep 10, 2019 —
CORRESP Letter to the SEC Aug 30, 2019 —
S-3/A Filing Aug 30, 2019 —
UPLOAD Letter from the SEC Aug 29, 2019 —
S-3 Shelf registration Aug 23, 2019 —
10-Q Quarterly report Aug 1, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 1, 2019 Aug 1, 2019
EFFECT Filing Jun 6, 2019 —
CORRESP Letter to the SEC Jun 4, 2019 —
8-K Current report
Shareholder vote results
May 22, 2019 May 21, 2019
CT ORDER Filing May 9, 2019 —
10-Q Quarterly report May 2, 2019 Mar 31, 2019
10-Q/A Amended quarterly report May 2, 2019 Sep 30, 2018
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
DEF 14A Proxy statement Apr 16, 2019 May 21, 2019
8-K Current report
Material agreement
Apr 5, 2019 Apr 5, 2019
CT ORDER Filing Mar 11, 2019 —
UPLOAD Letter from the SEC Mar 11, 2019 —
S-8 Employee stock plan registration Feb 27, 2019 —
POS AM Filing Feb 27, 2019 —
10-K Annual report Feb 27, 2019 Dec 31, 2018
POSASR Filing Feb 27, 2019 —
8-K Current report
Results of operations
Feb 27, 2019 Feb 27, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
NTLA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Large accelerated filer
SEC CIK
1652130

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.